Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Exscientia plc (EXAI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.58-0.52 (-4.30%)
At close: 04:00PM EDT
12.15 +0.57 (+4.92%)
After hours: 06:59PM EDT
Advertisement

Exscientia plc

The SchrOedinger Building
Oxford Science Park
Oxford OX4 4GE
United Kingdom
44 18 6581 8941
https://www.exscientia.ai

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees285

Key Executives

NameTitlePayExercisedYear Born
Prof. Andrew L. Hopkins DPHIL, FRSE FRSCFounder, CEO & Exec. DirectorN/AN/A1973
Mr. Ben Ashwell-FryerVP of Fin.N/AN/AN/A
Mr. Ben R. TaylorCFO, Chief Strategy Officer & Exec. DirectorN/AN/A1977
Ms. Heather TogwellOperations Mang.N/AN/AN/A
Dr. David Hallett Ph.D.Chief Operating OfficerN/AN/A1971
Dr. Garry Pairaudeau Ph.D.Chief Technology OfficerN/AN/A1967
Ms. Eileen Jennings-BrownChief Information OfficerN/AN/AN/A
Ms. Sara ShermanVP of Investor RelationsN/AN/AN/A
Mr. Dan IrelandVP of LegalN/AN/AN/A
Ms. Amanda GalgayVP of CommunicationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Corporate Governance

Exscientia plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement